72 Investment Holdings LLC's Q1 2022 13F: 1 position resized, no new positions or exits
Form 13F-HR for the quarter ended Mar 31, 2022 · filed May 16, 2022 · 6 reported positions · accession 0001567619-22-010957
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Reduced | ENTRADA THERAPEUTICS INC (TRDA) | 7.7% | 5.2% | −2.5 pts | −1 sh | 0% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 100.0% of the equity book
No changes in the top 10 this quarter
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | PROMETHEUS BIOSCIENCES INC (RXDX) | 64.8% | 76.3% | |
| 2 | PRAXIS PRECISION MEDICINES I (PRAX) | 17.3% | 11.0% | |
| 3 | ENTRADA THERAPEUTICS INC (TRDA) | 7.7% | 5.2% | |
| 4 | CARIBOU BIOSCIENCES INC (CRBU) | 6.3% | 4.8% | |
| 5 | OMEGA THERAPEUTICS INC (OMGA) | 3.5% | 2.4% | |
| 6 | WEWORK INC (WE) | 0.2% | 0.2% |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).